<prompt> Answer this question truthfullyWhat is the potential risk for patients on erythropoiesis-stimulating agents and why?  <response>: <reason> Patients on erythropoiesis-stimulating agents are associated with increased risk for thromboembolic events due to increased blood viscosity. 